BakerHostetler is proud to announce that Beverly Lyman, Ph.D., has joined the firm as a partner in the Intellectual Property practice as a member of the Biotechnology, Chemical and Pharmaceutical team. She is resident in the Cincinnati and Atlanta offices. Lyman was previously at Thompson Hine.

Lyman brings more than 20 years of experience as a life sciences transactional patent attorney. Her strategic and efficient counsel focuses on clients’ business goals to bring their IP potential to the forefront to leverage assets and maximize portfolio value. She advises clients on all aspects of intellectual property law, including patent procurement, licensing, evaluation and enforcement. Her extensive work in transactions and IP monetization helps companies commercialize innovative technologies and bring products to the marketplace. She represents corporations, early-stage companies, entrepreneurs, universities and physicians across the biotechnology, pharmaceutical, medical device and chemical industries. Lyman has represented global life science corporations in cutting-edge technologies such as Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR). Previously, she was a faculty member of the University of Tennessee where she taught biotechnology and chemical patent strategy, as well as taught IP licensing at the University of Cincinnati College of Law. Lyman’s former academic career guides her understanding of commercial integration among academic institutions from the undergraduate level to professional schools.

Lyman is registered to practice before the U.S. Patent and Trademark Office and is admitted in Ohio and Georgia. She has led and argued ex parte and inter partes reviews and appeals, and post-grant proceedings. She handles contracts, joint development agreements, material transfers and affiliations. She has advised clients on the development and commercialization of FDA-approved synthetics for burn patients; medical devices that manage pain; applications to treat burns and pathologies; compounds used in diagnostic imaging; topical solutions to treat eye conditions; and compounds to treat wounds and diabetic ulcers.

“Beverly is a valuable asset to our national practice,” said Mark Tidman, chair of BakerHostetler’s Intellectual Property Group. “Her skills, knowledge of advanced sciences and pragmatic approach to offering creative strategies will benefit corporate clients and open doors for academic researchers.”

Lyman is a nationally ranked Chambers USA intellectual property attorney. She was recognized by the Ohio Diversity Council among its Top Business Women in Ohio in 2017. Lyman is a member of the American Bar Association’s Health Law Section.

Lyman follows the recent addition of two intellectual property litigation partners earlier this month. These recent additions enhance the continued growth of the IP group and bolster the firm’s national intellectual property footprint. BakerHostetler’s Intellectual Property Group has more than 160 dedicated IP attorneys, with more than 100 lawyers and patent agents registered to practice before the U.S. Patent and Trademark Office. More than 50 of its IP attorneys hold advanced degrees across a spectrum of scientific disciplines.